December 2022 Legislative & Regulatory Briefing: The PIE Act Makes Waves in Washington D.C.; Member Benefit! Read the Latest Regulatory NewsBREAKs; AMCP CEO Susan A. Cantrell Applauds Reintroduction of the PIE Act; AMCP Joins Pharmacy Organizations in Request for Medicaid Guidance to States; AMCP's Adam Colborn Featured in Politico Pro.
Review this sponsored webinar to understand how to utilize real-time continuous glucose monitoring (RT-CGM) and overcome barriers for improved glycemic outcomes that may help social determinants of health inequities.
On Dec. 15, AMCP joined 29 other pharmacy organizations in a letter calling on the Centers for Medicare and Medicaid Services to build upon the Public Readiness and Emergency Preparedness Act with guidance clarifying that states should reimburse clinical services provided by pharmacists at the same rates as other non-physician providers.
Andrey Ostrovsky, MD, FAAP, and Lisa Palko, PharmD, discuss the ADHD landscape, challenges, and progress, including Akili's digital therapeutics value proposition as the first FDA-authorized prescription video game treatment.
The objective of this sponsored webinar is to talk about the complexities of Parkinson’s Disease and to provide an overview of the treatment options that are currently available.
This sponsored webinar will enable participants to review the pathophysiology, clinical manifestations, and disease course of lupus; describe the importance and key components of disease modification in lupus; discuss treatment goals and outcomes assessments focused on changing the course of disease.